7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase

被引:74
作者
Balzarini, J
Gamboa, AE
Esnouf, R
Liekens, S
Neyts, J
De Clercq, E
Camarasa, MJ
Pérez-Pérez, MJ
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] CSIC, Inst Quim Med, Madrid 28006, Spain
关键词
thymidine phosphorylase; angiogenesis; 7-deazaxanthine; 6-amino-5-bromouracil; TPase inhibitor;
D O I
10.1016/S0014-5793(98)01271-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
7-Deazaxanthine (7DX) was identified as a novel inhibitor of thymidine (dThd) phosphorylase (TPase). It inhibited the TPase reaction in a concentration-dependent manner. At 1 mM, it almost completely prevented the TPase-catalysed hydrolysis of dThd to thymine. The 50% inhibitory concentration (IC50) Of 7DX was 40 mu M in the presence of 100 mu M of the natural substrate dThd. 7DX is also endowed with a marked inhibitory effect on angiogenesis. It significantly prevents neovascularisation in the chicken chorioallantoic membrane during development. 7DX is the first purine derivative shown to be a potent inhibitor of purified TPase and angiogenesis. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 21 条
  • [1] PHOSPHOROLYSIS OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE (BVDU) AND OTHER 5-SUBSTITUTED-2'-DEOXYURIDINES BY PURIFIED HUMAN THYMIDINE PHOSPHORYLASE AND INTACT BLOOD-PLATELETS
    DESGRANGES, C
    RAZAKA, G
    RABAUD, M
    BRICAUD, H
    BALZARINI, J
    DECLERCQ, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1983, 32 (23) : 3583 - 3590
  • [2] The angiogenic factor platelet-derived endothelial cell growth factor thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium
    Fox, SB
    Westwood, M
    Moghaddam, A
    Comley, M
    Turley, H
    Whitehouse, RM
    Bicknell, R
    Gatter, KC
    Harris, AL
    [J]. BRITISH JOURNAL OF CANCER, 1996, 73 (03) : 275 - 280
  • [3] ANGIOGENIC FACTOR
    FURUKAWA, T
    YOSHIMURA, A
    SUMIZAWA, T
    HARAGUCHI, M
    AKIYAMA, S
    FUKUI, K
    ISHIZAWA, M
    YAMADA, Y
    [J]. NATURE, 1992, 356 (6371) : 668 - 668
  • [4] Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy
    Griffiths, L
    Stratford, IJ
    [J]. BRITISH JOURNAL OF CANCER, 1997, 76 (06) : 689 - 693
  • [5] ANGIOGENIC ACTIVITY OF ENZYMES
    HARAGUCHI, M
    MIYADERA, K
    UEMURA, K
    SUMIZAWA, T
    FURUKAWA, T
    YAMADA, K
    AKIYAMA, S
    YAMADA, Y
    [J]. NATURE, 1994, 368 (6468) : 198 - 198
  • [6] NEOVASCULAR RESPONSES INDUCED BY CULTURED AORTIC ENDOTHELIAL-CELLS
    HARRISHOOKER, SA
    GAJDUSEK, CM
    WIGHT, TN
    SCHWARTZ, SM
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1983, 114 (03) : 302 - 310
  • [7] HITCHINGS GH, 1959, Patent No. 812366
  • [8] Igarashi M, 1998, CANCER, V82, P1225, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1225::AID-CNCR3>3.0.CO
  • [9] 2-E
  • [10] Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma
    Imazono, Y
    Takebayashi, Y
    Nishiyama, K
    Akiba, S
    Miyadera, K
    Yamada, Y
    Akiyama, S
    Ohi, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) : 2570 - 2578